FFilingSight

Procter & Gamble (PG) 10-K Red Flags

Risk signals extracted deterministically from Procter & Gamble’s SEC 10-K/10-Q XBRL filings — no LLM, every finding cites the underlying data.

Detected red flags (15)

  • Restatement of financial statements: The term "restatement of" "previously issued" appears in 5 recent filing(s) (vs 1 in the prior period). This risk language is ongoing.
  • Operating cash flow exceeds net income: OCF is 1.22x net income, indicating high earnings quality — cash conversion is strong and accruals are not inflating reported profits.
  • Goodwill is 33% of total assets: Goodwill of $41.28B represents a large share of the balance sheet. If acquired businesses underperform, a non-cash impairment charge could materially impact earnings. Monitor segment performance and acquisition integration metrics.
  • Endogenous analysis: 1 positive signal(s) versus 1 risk signal(s). The filing exhibits more constructive indicators than concerns, though individual risk factors should still be monitored.
  • 20 new XBRL disclosure(s) in latest filing — expanding reporting scope.
  • 8 disclosure(s) dropped from prior year — reduced reporting granularity.
  • Ongoing high-severity risk language: Restatement of financial statements.
  • Market cap $335.60B at $144.38 per share.
  • Trailing P/E 21.81, P/S 3.86, P/B 6.18.
  • Price $144.38 — downtrend (below 200-DMA); 1-month momentum negative.
  • RSI(14) 51.64.
  • Composite risk: Elevated.
  • Leverage debt/equity 0.43 (moderate).
  • Restatement of financial statements: The term "restatement of" "previously issued" appears in 5 recent filing(s) (vs 1 in the prior period). This risk language is ongoing.
  • Operating cash flow exceeds net income: OCF is 1.22x net income, indicating high earnings quality — cash conversion is strong and accruals are not inflating reported profits.

Filings & ownership

  • Latest annual report (10-K) filed Aug 4, 2026.
  • Latest quarterly report (10-Q) filed Apr 24, 2026.
  • 14 recent 8-K material-event filings in the index.
  • Recent insider Form 4s: 0 buy vs 0 sell transactions.
  • ~10,000+ recent 13F-HR filings reference Procter & Gamble; broad institutional reporting.
  • Recent filers include LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS /MA, LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS /MA, LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS /MA.
  • 6 recent 13D activist/beneficial-ownership filings — potential catalyst.
  • 14 recent 13G passive institutional ownership notices.

Full PG analyst report

Valuation (DCF & Graham), technicals, macro exposure, risk scorecard and 13F/13D ownership.

View full report →

Not investment advice. FilingSight is an automated analytical research tool, not a registered investment advisor. Ratings and scores are quantitative analytical classifications, not buy or sell recommendations. Nothing here is personalized to your circumstances. Investing involves risk of loss — consult a licensed professional. See full disclosures.